249 related articles for article (PubMed ID: 23369450)
1. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer.
Gobbi PG; Bergonzi M; Comelli M; Villano L; Pozzoli D; Vanoli A; Dionigi P
Cancer Epidemiol; 2013 Apr; 37(2):186-90. PubMed ID: 23369450
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
3. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
4. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic delay does not influence survival of pancreatic cancer patients.
Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
[TBL] [Abstract][Full Text] [Related]
7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
8. [The periampullary carcinoma. Clinical and therapeutic alternatives].
Popovici A; Popescu I; Ionescu MI; Vasilescu C; Ciurea S; Tonea A; David L
Chirurgia (Bucur); 2000; 95(5):407-24. PubMed ID: 14870550
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
10. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
Kawaida H; Fujii H
Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
[No Abstract] [Full Text] [Related]
12. Clinicopathological features of giant cell carcinoma of the pancreas.
Zou XP; Yu ZL; Li ZS; Zhou GZ
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):300-2. PubMed ID: 15138131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
[TBL] [Abstract][Full Text] [Related]
14. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract][Full Text] [Related]
15. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer.
Eguchi H; Nagano H; Tanemura M; Takeda Y; Marubashi S; Kobayashi S; Kawamoto K; Wada H; Hama N; Akita H; Mori M; Doki Y
Hepatogastroenterology; 2013 Jun; 60(124):904-11. PubMed ID: 23321032
[TBL] [Abstract][Full Text] [Related]
18. [Trends for the management of pancreatic adenocarcinoma in a hospitalized-based population (1980-1994)].
Queneau PE; Pitard A; Labourey JM; Koch S; Sauve G; Carayon P
Gastroenterol Clin Biol; 2000 May; 24(5):501-5. PubMed ID: 10891737
[TBL] [Abstract][Full Text] [Related]
19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
20. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]